NCT05777460 Mid- and Long-term Outcomes of Custom-made Aortic Devices
| NCT ID | NCT05777460 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Aortic Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2020-10-01 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2020-10-01 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate mid- and long-term outcomes after Thoracic endovascular aortic repair (TEVAR) with custom-made devices.
Eligibility Criteria
Inclusion Criteria: * Thoracic Aortic Disease Exclusion Criteria: * Urgent/Emergent treatment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05777460 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05777460 currently recruiting?
Yes, NCT05777460 is actively recruiting participants. Contact the research team at giovanni.tinelli@policlinicogemelli.it for enrollment information.
Where is the NCT05777460 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT05777460 clinical trial?
NCT05777460 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 60 participants.